Stock Report Alnylam Pharmaceuticals Inc with In-Depth Stock Analysis

Alnylam Pharmaceuticals Inc XNAS: ALNY

Momentum Trap

283.34 29.80 (11.75%)

3.1M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Target Upgrade

Scotiabank raises Alnylam's target price by 12% to $338 after it gets FDA nod for drug Amvuttra See details

Detailed Stock Analysis for Alnylam Pharmaceuticals Inc with Real-time Stock Report